Bridgelink Advisors Private Limited
Founded: 1997
Status: Active
Designation: Director
MS
Manikkan Sangameswaran, Director and Non- Individual Subscriber, with 47 companies.
Manikkan Sangameswaran has 27 years in corporate governance. Holds Director and Non- Individual Subscriber roles. Currently with 13 companies, including Bridgelink Advisors Private Limited and Mns Properties Private Limited. Formerly with 34 companies, such as Radiance Renewables Private Limited and Mns Properties Private Limited. Engaged in General Business, Technology and more.
Founded: 1997
Status: Active
Designation: Director
Founded: 2007
Status: Converted To Llp
Designation: Director
Founded: 2023
Status: Active
Designation: Non- Individual Subscriber
Founded: 2025
Status: Active
Designation: Designated Partner
Founded: 2025
Status: Active
Designation: Non- Individual Subscriber
Founded: 2025
Status: Active
Designation: Non- Individual Subscriber
Founded: 2018
Status: Active
Designation: Whole-Time Director
Founded: 2007
Status: Converted To Llp
Designation: Additional Director
Founded: 1997
Status: Active
Designation: Director
Founded: 2013
Status: Active
Designation: Additional Director
Founded: 2007
Status: Dissolved (Liquidated)
Designation: Managing Director
Founded: 2007
Status: Converted To Llp
Designation: Director
Explore Director's current and past company associations— Uncover their professional journey today!
Manikkan Sangameswaran has 27 years in corporate governance. Holds Director and Non- Individual Subscriber roles. Currently with 13 companies, including Bridgelink Advisors Private Limited and Mns Properties Private Limited. Formerly with 34 companies, such as Radiance Renewables Private Limited and Mns Properties Private Limited. Engaged in General Business, Technology and more.
Manikkan Sangameswaran is associated with 13 companies as Director and Non- Individual Subscriber.
Manikkan Sangameswaran has expertise in General Business, Technology and other sectors.
Manikkan Sangameswaran has 27 years in corporate governance.